午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

2-[5-(4-methylbenzylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]-N-(5-methyl-1,3,4-thiadiazol-2-yl)acetamide

CAS No.
301158-32-7
Chemical Name:
2-[5-(4-methylbenzylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]-N-(5-methyl-1,3,4-thiadiazol-2-yl)acetamide
Synonyms
3-Thiazolidineacetamide, 5-[(4-methylphenyl)methylene]-N-(5-methyl-1,3,4-thiadiazol-2-yl)-4-oxo-2-thioxo-;2-[5-(4-methylbenzylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]-N-(5-methyl-1,3,4-thiadiazol-2-yl)acetamide
CBNumber:
CB61948617
Molecular Formula:
C16H14N4O2S3
Molecular Weight:
390.5
MDL Number:
MOL File:
301158-32-7.mol

2-[5-(4-methylbenzylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]-N-(5-methyl-1,3,4-thiadiazol-2-yl)acetamide Properties

Density 1.51±0.1 g/cm3(Predicted)
pka 7.80±0.50(Predicted)

2-[5-(4-methylbenzylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]-N-(5-methyl-1,3,4-thiadiazol-2-yl)acetamide Preparation Products And Raw materials

Raw materials

Preparation Products

2-[5-(4-methylbenzylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]-N-(5-methyl-1,3,4-thiadiazol-2-yl)acetamide Suppliers

Global( 3)Suppliers
Supplier Tel Email Country ProdList Advantage
Interbioscreen Ltd. -- screen@ibscreen.chg.ru Finland 6176 60
PHARMEKS Ltd. -- sales@pharmeks.com Finland 6349 50
Specs -- info@specs.net The Netherlands 6833 70
Supplier Advantage
Interbioscreen Ltd. 60
PHARMEKS Ltd. 50
Specs 70
2-[5-(4-methylbenzylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]-N-(5-methyl-1,3,4-thiadiazol-2-yl)acetamide 3-Thiazolidineacetamide, 5-[(4-methylphenyl)methylene]-N-(5-methyl-1,3,4-thiadiazol-2-yl)-4-oxo-2-thioxo- 301158-32-7 C16H14N4O2S3
This site uses cookies
This website uses cookies and similar technologies to store and retrieve information about your use of this website. This information helps us to provide, analyse and improve our services, which may include personalised content or advertising. We may share this information with Google and other third parties. This cookies are necessary for our website to work properly . By clicking "Continue" or continuing to browse our site you are agreeing to our and our partners use of cookies.
Accept